Cargando…
Pharmacological Control of Receptor of Advanced Glycation End-Products and its Biological Effects in Psoriasis
Receptor for advanced glycation end-products is implicated in a development of chronic inflammatory response. Aim of this paper is to provide a review on commercial and experimental medicines that can interfere with RAGE and signaling through RAGE. We searched three bibliographical databases (PubMed...
Autores principales: | Mezentsev, A. V., Bruskin, S. A., Soboleva, A. G., Sobolev, V. V., Piruzian, E. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Master Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809352/ https://www.ncbi.nlm.nih.gov/pubmed/24170986 |
Ejemplares similares
-
Three-Dimensional Model of Mouse Epidermis for Experimental Studies of Psoriasis
por: Soboleva, A.G., et al.
Publicado: (2013) -
Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023) -
Proteomic Studies of Psoriasis
por: Sobolev, Vladimir V., et al.
Publicado: (2022) -
Advanced Glycation End Products in the Pathogenesis of Psoriasis
por: Papagrigoraki, Anastasia, et al.
Publicado: (2017) -
The Role of Transcription Factor PPAR-γ in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells
por: Sobolev, Vladimir V., et al.
Publicado: (2022)